Hepatitis E Virus (HEV) Infection Among Immunocompromised Individuals: A Brief Narrative Review
Radostina Alexandrova,Ilia Tsachev,Plamen Kirov,Abedulkadir Abudalleh,Hristo Hristov,Tanya Zhivkova,Lora Dyakova,Magdalena Baymakova
DOI: https://doi.org/10.2147/idr.s449221
2024-03-14
Infection and Drug Resistance
Abstract:Radostina Alexandrova, 1 Ilia Tsachev, 2 Plamen Kirov, 1 Abedulkadir Abudalleh, 1 Hristo Hristov, 1 Tanya Zhivkova, 1 Lora Dyakova, 3 Magdalena Baymakova 4 1 Department of Pathology, Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, Sofia, Bulgaria; 2 Department of Microbiology, Infectious and Parasitic Diseases, Faculty of Veterinary Medicine, Trakia University, Stara Zagora, Bulgaria; 3 Department of Synaptic Signaling and Communication, Institute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria; 4 Department of Infectious Diseases, Military Medical Academy, Sofia, Bulgaria Correspondence: Magdalena Baymakova, Department of Infectious Diseases, Military Medical Academy, Sofia, Bulgaria, Tel +359-882-28-50-87, Email Hepatitis E virus (HEV) is a single-stranded positive-sense RNA virus that belongs to Hepeviridae family. HEV is the most common cause of acute viral hepatitis worldwide. According to the World Health Organization (WHO), there are estimated 20 million HEV infections worldwide every year, leading to estimated 3.3 million symptomatic cases of HEV infection. The WHO estimates that HEV infection caused approximately 44,000 deaths in 2015, which represents 3.3% of mortality rates due to viral hepatitis. In low-income (LI) countries and lower-middle-income (LMI) countries, HEV is a waterborne infection induced by HEV genotype (gt) 1 and HEV gt 2 that cause large outbreaks and affect young individuals with a high mortality rate in pregnant women from South Asian countries and patients with liver diseases. HEV gt 3, HEV gt 4, and HEV gt 7 are responsible for sporadic infections with zoonotic transmission mainly through the consumption of raw or undercooked meat from different animals. Acute HEV infection is relatively asymptomatic or mild clinical form, in rare cases the disease can be moderate/severe clinical forms and result in fulminant hepatitis or acute liver failure (ALF). Furthermore, HEV infection is associated with extrahepatic manifestations, including renal and neurological clinical signs and symptoms. Pregnant women, infants, older people, immunocompromised individuals, patients with comorbidities, and workers who come into close contact with HEV-infected animals are recognized as major risk groups for severe clinical form of HEV infection and fatal outcome. Chronic HEV infection can occur in immunocompromised individuals with the possibility of progression to cirrhosis. Keywords: acute and chronic infection, cancer, cirrhosis, hepatitis E virus, HEV, HIV, solid organ transplants The hepatitis E virus (HEV) is the fifth known viral hepatitis (after A, B, C, and D) and the most common cause of acute viral hepatitis worldwide. 1–5 It attracts the attention of the health community during an epidemic of the so-called non-A, non-B hepatitis in Kashmir, India, in 1978. 1–5 HEV was discovered by immune electron microscopy in 1983 by Balayan et al, who were investigating an outbreak of unexplained hepatitis among Soviet (Russian) soldiers situated in Afghanistan. 6 The genome of the virus was sequenced in 1991. 1,4 In the same year, a diagnostic test for its detection was developed. 5 Nowadays about twenty million HEV infections occur annually worldwide, resulting in approximately 3.3 million symptomatic cases with more than 70 thousand associated deaths and 3000 stillbirths mainly in Asia and Africa. 1,7 One-third of the world's population has been exposed to HEV. 1,7 The incubation period of HEV is 2 to 6 weeks. 8 The main sites of HEV replication are the liver as well as extrahepatic organs, including the small intestine, colon, spleen, stomach, kidney, and placenta. 9,10 In general, acute HEV infection is a relatively asymptomatic or mild clinical form presenting with elevated liver enzymes (alanine aminotransferase, ALT, and aspartate aminotransferase, AST), fatigue, dark urine, abdominal pain, jaundice, malaise, nausea/vomiting, muscle pain, and pale stools. 4,11 Acute icteric hepatitis is noted in around 5–30% of patients infected by HEV. 9 These clinical signs usually last 1–6 weeks and are frequently similar to those observed in other liver diseases. 4 In low-income (LI) countries and lower middle-income (LMI) countries, the virus affects especially badly pregnant women (especially those in the second or third trimester) and neonates; case fatality rates (CFR) of 20–30%. 9,12 It is not clear why pregnant women are at greater risk as no suitable animal model exists, but it is thought to be related to changes in hormone levels during pregnancy and their ef -Abstract Truncated-
pharmacology & pharmacy,infectious diseases